- Facultat de Medicina
Center
![Foto de - Facultat de Medicina](/img/noimage.png)
![Foto de University of Glasgow](/img/noimage_org.png)
University of Glasgow
Glasgow, Reino UnidoPublications in collaboration with researchers from University of Glasgow (25)
2024
-
COVID-19 and cardiovascular disease in patients with chronic kidney disease
Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 177-189
-
Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease
Clinical Kidney Journal, Vol. 17, Núm. 3
2023
-
Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis
JAMA, Vol. 330, Núm. 13, pp. 1266-1277
-
Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study
European heart journal, Vol. 44, Núm. 13, pp. 1157-1166
-
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease
Nephrology Dialysis Transplantation, Vol. 38, Núm. 1, pp. 10-25
-
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy
Gut, Vol. 73, Núm. 3, pp. 496-508
-
Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline ☆
ESMO Open, Vol. 8, Núm. 2
-
SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2444-2455
2022
-
PEGASO e-Diary: User Engagement and Dietary Behavior Change of a Mobile Food Record for Adolescents
Frontiers in Nutrition, Vol. 9
-
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery
BJS Open, Vol. 6, Núm. 1
2021
-
Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies (Drugs, (2021), 81, 13, (1467-1489), 10.1007/s40265-021-01555-5)
Drugs
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
Drugs, Vol. 81, Núm. 13, pp. 1467-1489
-
Intravenous iron therapy and the cardiovascular system: risks and benefits
Clinical Kidney Journal, Vol. 14, Núm. 4, pp. 1067-1076
-
Same rhythm, different song-Approaches to atrial fibrillation management by cardiologists and nephrologists
Clinical Kidney Journal, Vol. 14, Núm. 1, pp. 9-13
2020
-
Confirmation of the Cardioprotective Effect of MitoGamide in the Diabetic Heart
Cardiovascular Drugs and Therapy, Vol. 34, Núm. 6, pp. 823-834
2019
-
Erratum to: Lipid management in patients with chronic kidney disease (Nature Reviews Nephrology, (2018), 14, 12, (727-749), 10.1038/s41581-018-0072-9)
Nature Reviews Nephrology
-
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
Database, Vol. 2019, pp. 1-67
2018
-
Lipid management in patients with chronic kidney disease
Nature Reviews Nephrology, Vol. 14, Núm. 12, pp. 727-749
2017
-
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
New England Journal of Medicine, Vol. 377, Núm. 13, pp. 1228-1239